Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-11-14 Purchase |
2024-11-18 7:20 pm |
Tango Therapeutics Inc. | TNGX | Rothenberg Mace Director |
20,000 | $3.7 | $74,000 | 31,250 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-06-05 Option Award |
2024-06-07 5:17 pm |
N/A 2034-06-05 |
Tango Therapeutics Inc. | TNGX | Rothenberg Mace Director |
43,750 | $0 | 48,750 (Direct) |
View |
2024-06-05 Option Award |
2024-06-06 8:30 pm |
2025-06-05 2034-06-05 |
Surrozen Inc. | SRZN | Rothenberg Mace Director |
1,333 | $0 | 1,333 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 9:40 pm |
N/A 2033-06-06 |
Tango Therapeutics Inc. | TNGX | Rothenberg Mace Director |
35,000 | $0 | 35,000 (Direct) |
View |
2023-05-18 Option Award |
2023-05-19 4:17 pm |
2023-06-18 2033-05-18 |
Surrozen Inc. | SRZN | Rothenberg Mace Director |
20,000 | $0 | 20,000 (Direct) |
View |
2022-06-08 Option Award |
2022-06-28 4:27 pm |
N/A 2032-06-08 |
Tango Therapeutics Inc. | TNGX | Rothenberg Mace Director |
40,000 | $0 | 40,000 (Direct) |
View |
2022-06-07 Option Award |
2022-06-09 5:50 pm |
2023-06-07 2032-06-07 |
Surrozen Inc. | SRZN | Rothenberg Mace Director |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership |
2021-08-16 7:49 pm |
N/A N/A |
Surrozen Inc. | SRZN | Rothenberg Mace Director |
0 | $0 | 35,129 (Direct) |
View |
Ownership |
2021-08-12 8:38 pm |
N/A 2031-03-18 |
Tango Therapeutics Inc. | TNGX | Rothenberg Mace Director |
0 | $0 | 84,929 (Direct) |
View |